E
E. George Elias
Researcher at University of Maryland, Baltimore
Publications - 22
Citations - 704
E. George Elias is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Melanoma & Adjuvant therapy. The author has an hindex of 13, co-authored 22 publications receiving 696 citations. Previous affiliations of E. George Elias include University of Maryland Medical System & University of Maryland Medical Center.
Papers
More filters
Journal ArticleDOI
Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients
TL;DR: A clinicopathologic study of 42 patients with histologically proven adrenal cortical carcinoma from Roswell Park Memorial Institute found an aggressive surgical approach is recommended to extirpate the tumor with involved organs and retroperitoneal lymph nodes to improve survival.
Journal ArticleDOI
Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.
E. George Elias,Paul B. Chretien,Edgar Monnard,Tariq Khan,William H. Bouchelle,Peter H. Wiernik,Stephen D. Lipson,Kenneth R. Hande,Theresa A. Zentai +8 more
TL;DR: This combination chemotherapy seemed to be very effective in squamous cell carcinoma of the head and neck and could be applied prior to local‐regional therapy and should be carried out only in centers that have adequate facilities for close monitoring of the patients.
Journal ArticleDOI
Serum glycoproteins in head and neck squamous carcinoma: Correlations with tumor extent, clinical tumor stage, and T-cell levels during chemotherapy
Gregory T. Wolf,Paul B. Chretien,E. George Elias,Robert W. Makuch,Arnold M. Baskies,Herbert E. Spiegel,Joseph F. Weiss +6 more
TL;DR: Serum levels show that α 1 -antitrypsin and α 1-acid glycoprotein correlate better with AJC tumor stage than cellular immune parameters previously studied and that α 2 HS-glycoprotein levels may be as useful as T-cell levels for monitoring immune reactivity in patients with squamous cancer of the head and neck.
Journal ArticleDOI
Chemotherapy for Metastatic Basal Cell Carcinoma
TL;DR: A 63-year-old woman with an extensive primary keratinizing basal cell carcinoma of the scalp, with metastases to the regional lymph nodes of the neck, had skeletal metastases that responded to therapy with three courses of cisplatin and bleomycin sulfate and then to ten courses of cyclophosphamide, methotrexate, and fluorouracil.
Journal ArticleDOI
Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor‐associated antigens (TAA). A phase I clinical trial
Ariel C. Hollinshead,E. George Elias,Myron Arlen,Barbara S. Buda,Maria Mosley,Joseph Scherrer +5 more
TL;DR: These studies justify a Phase II‐III trial in a larger number of patients and have provided selection of appropriate monitoring tests for the larger trial.